Endo’s ‘Effective’ Short Interest Exceeds GameStop, AMC
I am a major Endo (ENDP) bull. However, I would be remiss in not admitting that it has been one of the market's most...
Novavax Is 50% Overvalued
Novavax's (NVAX) COVID-19 vaccine demonstrated 89% efficacy in clinical trials. This should allow it to compete head-to-head against Pfizer (PFE) and Moderna (MRNA) whose...
Moderna, Jim Cramer Tweaking So Hard, Skully’s Taking Pictures
Moderna (MRNA) received Emergency Use Authorization for its COVID-19 vaccine in Q4 2020 and the stock exploded. In late December, the upside appeared priced...
Michaels Is Worth $44
The Michaels Companies (MIK) reported earnings March 4th. Analysts expected revenue of $1.81 billion and EPS of $1.41. The revenue estimate implied mid-single-digit percentage...
DMX, Drink Champs Explain Why ‘Shock Exchange’ Was Prince’s Favorite Book
Prince by all accounts was a musical genius. He sang the songs, wrote his lyrics, managed several bands and played several different instruments. He...
Johnson & Johnson’s COVID-19 Vaccine Could Punish Moderna, Novavax
Back in November it was uncertain whether big pharma could develop a vaccine to combat the coronavirus. Today at least four firms have garnered...
Cramer’s PR Stunt Implies Moderna Could Crater
Moderna posted an incredible earnings report yesterday. The company reported revenue of $571 million. Revenue is growing by leaps and bounds as new COVID-19...
Endo’s Next Catalyst Emerges
I am a major Endo (ENDP) bull. However, I would be remiss in not admitting that it has been one of the market's most...
How Warren Buffett Triggered Teva’s Epic Short Squeeze
The opioid epidemic continues to dominate the public discourse. The question remains, "What can be done about it?" The number of accidental deaths related...
Counties Rush To Sign Opioid Settlement Before Deadline
Two years ago President Trump was highly critical of opioid drug manufacturers. He wanted to shed more light on their role in the opioid...
